Tin tức & Cập nhật

Recurrence scores from 21-gene assay help inform benefits of adjuvant anthracyclines in EBC
Recurrence scores from 21-gene assay help inform benefits of adjuvant anthracyclines in EBC
26 Jan 2025 bởiMike Ng

The recurrence score derived from a 21-gene expression assay may indicate which patients with early-stage HR+ breast cancer can maintain freedom from distant recurrence for longer with the inclusion of an anthracycline in adjuvant chemotherapy, suggests a post hoc analysis of the TAILORx trial presented at SABCS 2024

Recurrence scores from 21-gene assay help inform benefits of adjuvant anthracyclines in EBC
26 Jan 2025